Strahlentherapieplanung mit der funktionellen MRT

详细信息    查看全文

• 作者：PD Dr. P. Georg ; P. Andrzejewski ; K. Pinker ; D. Georg
• 关键词：Bildgesteuerte Strahlentherapie ; Funktionelle MRT ; Intensit盲tsmodulierte Strahlentherapie ; Ionentherapie ; 鈥淒ose painting鈥?/li> Image guided radiotherapy ; Functional magnetic resonance imaging ; Intensity modulated radiotherapy ; Ion beam therapy ; Dose painting
• 刊名：Der Radiologe
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：55
• 期：12
• 页码：1097-1103
• 全文大小：1,179 KB
• 参考文献：1.Bakker CJ, Moerland MA, Bhagwandien R, Beersma R (1992) Analysis of machine-dependent and object-induced geometric distortion in 2DFT MR imaging. Magn Reson Imaging 10:597鈥?08PubMed CrossRef
  2.Bentzen SM (2005) Theragnostic imaging for radiation oncology: dose-painting by numbers. Lancet Oncol 6:112鈥?17PubMed CrossRef
  3.Bentzen SM, Gregoire V (2011) Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol 21:101鈥?10PubMed PubMedCentral CrossRef
  4.Bickel H, Pinker-Domenig K, Bogner W et al (2015) Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ. Invest Radiol 50:95鈥?00PubMed CrossRef
  5.Bogner W, Pinker-Domenig K, Bickel H et al (2012) Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T. Radiology 263:64鈥?6PubMed CrossRef
  6.Buckley DL, Roberts C, Parker GJM et al (2004) Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging 鈥?initial experience. Radiology 233:709鈥?15PubMed CrossRef
  7.Fransson A, Andreo P, P枚tter R et al (2001) Aspects of MR image distortions in radiotherapy treatment planning. Strahlenther Onkol 177:59鈥?3PubMed CrossRef
  8.Gibbs P, Pickles MD, Turnbull LW (2007) Repeatability of echo-planar-based diffusion measurements of the human prostate at 3 T. Magn Reson Imaging 25:1423鈥?429PubMed CrossRef
  9.Groenendaal G, van den Berg CAT, Korporaal JG et al (2010) Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol 95:185鈥?90PubMed CrossRef
  10.Groenendaal G, Borren A, Moman MR et al (2012) Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys 82:e537鈥揺544PubMed CrossRef
  11.Harry VN, Semple SI, Gilbert FJ, Parkin DE (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213鈥?20PubMed CrossRef
  12.Kozlowski P, Chang SD, Meng R et al (2010) Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T 鈥?quantitative correlation with biopsy. Magn Reson Imaging 28:621鈥?28PubMed PubMedCentral CrossRef
  13.Lambregts DMJ, Beets GL, Maas M et al (2011) Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol 21:2567鈥?574PubMed PubMedCentral CrossRef
  14.Langer DL, van der Kwast TH, Evans AJ et al (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327鈥?34PubMed CrossRef
  15.Van Lin ENJT, F眉tterer JJ, Heijmink SWTPJ et al (2006) IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65:291鈥?03PubMed CrossRef
  16.Ling CC, Humm J, Larson S et al (2000) Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47:551鈥?60PubMed CrossRef
  17.Lips IM, van der Heide UA, Haustermans K et al (2011) Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial. Trials 12:255PubMed PubMedCentral CrossRef
  18.Mayr NA, Huang Z, Wang JZ et al (2012) Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. Int J Radiat Oncol Biol Phys 83:972鈥?79PubMed PubMedCentral CrossRef
  19.Petit SF, Dekker ALAJ, Seigneuric R et al (2009) Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study. Phys Med Biol 54:2179鈥?196PubMed CrossRef
  20.Pinker K, Bickel H, Helbich TH et al (2013) Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the 鈥濨reast Imaging Reporting and Data System鈥?for multiparametric 3-T imaging of breast lesions. Eur Radiol 23:1791鈥?802PubMed CrossRef
  21.Pinker K, Bogner W, Baltzer P et al (2014) Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Invest Radiol 49:421鈥?30PubMed CrossRef
  22.S酶vik 脜, Malinen E, Skogmo HK et al (2007) Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys 68:1496鈥?504PubMed CrossRef
  23.Sumanaweera TS, Glover GH, Binford TO, Adler JR (1993) MR susceptibility misregistration correction. IEEE Trans Med Imaging 12:251鈥?59PubMed CrossRef
  24.Thorwarth D, Eschmann S-M, Paulsen F, Alber M (2007) Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys 68:291鈥?00PubMed CrossRef
  25.Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223鈥?32PubMed CrossRef
  26.Turkbey B, Mani H, Aras O et al (2012) Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 188:1157鈥?163PubMed CrossRef
  27.Van Vulpen M, van den Berg CAT, Moman MR, van der Heide UA (2009) Difficulties and potential of correlating local recurrences in prostate cancer with the delivered local dose. Radiother Oncol 93:180鈥?84PubMed CrossRef
  28.Zahra MA, Tan LT, Priest AN et al (2009) Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74:766鈥?73PubMed CrossRef
  
• 作者单位：PD Dr. P. Georg (1) (2)
  P. Andrzejewski (2) (3)
  K. Pinker (2) (4)
  D. Georg (2) (3)
  
  1. EBG MedAustron GmbH, Marie-Curie-Stra脽e 5, 2700, Wiener Neustadt, 脰sterreich
  2. Christian Doppler Labor f眉r die Medizinische Strahlenforschung, Medizinische Universit盲t Wien, Wien, 脰sterreich
  3. Abteilung f眉r medizinische Strahlenphysik, Univ. Klinik f眉r Strahlentherapie, Medizinische Universit盲t Wien, Wien, 脰sterreich
  4. Abteilung f眉r molekulare Bildgebung, Univ. Klinik f眉r Radiologie und Nuklearmedizin, Medizinische Universit盲t Wien, Wien, 脰sterreich
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  General Practice and Family Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-2102

文摘

Clinical/methodical issue The aim of magnetic resonance imaging (MRI) guided radiotherapy is high precision in treatment delivery. With new developments it is possible to focus the high dose irradiation on the tumor while sparing the surrounding tissue. The achievements in precision of the treatment planning and delivery warrant equally precise tumor definition.